BioStock: BiBBInstruments at forefront of cancer diagnostics revolution

Fine needle instruments are being replaced by core needle biopsy instruments capable of delivering cleaner tissue samples for more accurate analysis, thus providing more reliable diagnostics. Swedish medtech BiBBInstruments is following the trend by developing the world’s first CE-marked endoscopic ultrasound-guided core needle biopsy device – EndoDrill. As the cancer burden increases, and as new precision medicine technologies that rely heavily on high quality tissue sampling hit the market, BiBB’s innovation could not come at a better time.

Read the article at biostock.se:

https://www.biostock.se/en/2022/04/bibbinstruments-at-forefront-of-cancer-diagnostics-revolution/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se